BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging & Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250704T133000
DTEND;TZID=Europe/Vienna:20250704T143000
DTSTAMP:20260407T141603
CREATED:20241017T075136Z
LAST-MODIFIED:20250630T084441Z
UID:1917-1751635800-1751639400@esmit.eanm.org
SUMMARY:Alpha Emitters – The Roadmap of the Big Ones!
DESCRIPTION:The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes\, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters\, such as their high linear energy transfer and short path length\, which allow for precise tumor cell killing with minimal damage to surrounding tissue. The seminar will also address key challenges\, including limited availability of suitable alpha-emitting radionuclides\, complex radiochemistry\, and safety concerns during production and handling. Emphasis will be placed on production routes\, chelation strategies\, and conjugation chemistry that enable targeted delivery to cancer cells. Finally\, the session will critically evaluate the therapeutic potential and limitations of alpha therapy\, highlighting areas for future research and clinical translation. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nParticipants will gain understanding of the advantages of alpha-emitters over beta emitter\n\n\n\nParticipants will be able to describe and explain challenges arising from applications of alpha-emitters\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nRadiochemist\, Radiopharmacists\, nuclear physicians with a research profile\, medicinal chemistry researchers\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nMatthias HerthSpeaker \n\n\n\n\n\nFilipe ElvasSpeaker \n\n\n\n\n\nDana NiculaeModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/alpha-emitters-the-roadmap-of-the-big-ones/
CATEGORIES:Live Webinars,Radiopharmaceuticals
END:VEVENT
END:VCALENDAR